Scott T. Rottinghaus

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

ENTA

Current role

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Enanta Pharmaceuticals Inc (ENTA)	Chief Medical Officer	$560,300	—	$53,563	$425,943	$281,348	$22,058	$1,343,212
2024	Enanta Pharmaceuticals Inc (ENTA)	Chief Medical Officer	$544,000	—	$58,272	$422,664	$210,040	$22,098	$1,257,074
2023	Enanta Pharmaceuticals Inc (ENTA)	Chief Medical Officer	$530,250	—	$577,080	$345,269	$190,678	$11,448	$1,654,724
2022	Enanta Pharmaceuticals Inc (ENTA)	Chief Medical Officer	$77,557	$62,500	$1,597,316	$2,628,960	$29,295	$337	$4,395,965
2021	Enanta Pharmaceuticals Inc (ENTA)	M.D.\ Senior Vice President and Chief Medical Officer	—	—	—	—	—	—	—
2020	Enanta Pharmaceuticals Inc (ENTA)	M.D.\ Senior Vice President and Chief Medical Officer	—	—	—	—	—	—	—

No earnings-call appearances or filed executive changes recorded yet.